Table 2.
Reference | Treatment Regimen | No. of Patients | |
---|---|---|---|
Treated | Survived | ||
Lorenz et al., 1983 (unpublished) | PE + SIL | 201 | 181 |
Strenge-Hesse et al., 1996 (unpublished) | PE + SIL | 154 | 139 |
Floersheim et al., 1982 [29] | PE + SIL | 16 | 16 |
Hruby 1983 [30] | PE + SIL | 15 | 14 |
Marugg and Reutter 1985 [33] | PE + SIL | 12 | 11 |
Smetana et al., 1986 [34] | PE + SIL | 2 | 2 |
Schenke et al., 1987 [35] | SIL | 2 | 2 |
Hruby 1987 [36] | SIL PE + SIL TH + SIL PE + TH + SIL |
17 37 1 15 |
16 34 1 15 |
Kelbel and Weilemann 1989 [37] | PE + SIL | 5 | 4 |
Nagy et al., 1994 [38] | PE + SIL | 4 | 3 |
Kleist-Retzow et al., 1995 [39] | PE + SIL | 2 | 2 |
Molling et al., 1995 [40] | PE + SIL | 2 | 2 |
Carducci et al., 1996 [41] | PE + SIL | 4 | 4 |
Alves et al., 2001 [42] | PE + SIL | 4 | 4 |
Boyer et al., 2001 [43] | NAC + SIL | 1 | 1 |
Enjalbert et al., 2002 [28] | SIL or PE+SIL | 624 | 589 |
Ganzert et al., 2008 [31] | SIL or PE+SIL | 367 | 339 |
Mitchell and Olson 2008 [32] | PE+NAC+SIL | 6 | 5 |
Total | 1,491 | 1,384 |
PE=penicillin, SIL=Legalon® SIL, NAC=N-acetylcysteine, TH=thioctic acid.